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Objective: Volume–outcome relationships for esophageal cancer resection have been well described with centers
of excellence defined by volume. No consensus exists for what constitutes a ‘‘high-volume’’ center. We aim to
determine if an objective evidence-based threshold of operative volume associated with improvement in operative
outcome for esophageal resections can be defined.
Methods: Retrospective analysis was performed on patients undergoing esophageal resection for cancer in the
1998 to 2005 Nationwide Inpatient Sample. A series of multivariable analyses were performed, changing the re-
section volume cutoff to account for the range of annual hospital resections. The goodness of fit of each model was
compared by pseudo r2, the amount of data variance explained by each model.
Results: A total of 4080 patients underwent esophageal resection. The median annual hospital resection volume
was 4 (range: 1–34). The mortality rate of ‘‘high-volume’’ centers ranged from 9.94% (2 resection/year) to
1.56% (30 resections/year). The best model was with an annual hospital resection volume greater than or equal
to 15 (3.87% of data variance explained). The difference in goodness of fit between the best model and other
models with different volume cutoffs was 0.64%, suggesting that volume explains less than 1% of variance
in perioperative death.
Conclusion: Our data do not support the use of volume cutoffs for defining centers of excellence for esophageal
cancer resections. Although volume has an incremental impact on mortality, volume alone is insufficient for de-
fining centers of excellence. Volume seems to function as an imperfect surrogate for other variables, which may
better define centers of excellence. Additional work is needed to identify these variables.See related article on page 10.
Resection of the esophagus, either total or partial, is a com-
plex surgical procedure that carries a relatively high risk of
operative mortality. Because of this, a significant body of
work has focused on the relationship between volume and
outcome for esophageal resections. The beneficial effect of
increased volume of esophagectomy on outcome has been
clearly demonstrated in multiple studies.1-4 On the basis of
the results of these and similar studies, esophageal resection
has been identified as a potential procedure for volume-
based regionalization, and as such resection volume has
been proposed as a measurement for defining centers of
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doi:10.1016/j.jtcvs.2008.09.040The Journal of Thoracic andexcellence. An example of this is the Leapfrog Group, which
defined criteria for ‘‘evidence-based hospital referral’’ for
esophageal resection as hospitals performing a minimum
of 13 resections per year.5
In addition to the volume cutoff for esophageal resections
set by the Leapfrog Group, various other thresholds for defin-
ing high-volume centers have been used in the literature. These
annual hospital volume thresholds range from 6 to 20 esoph-
ageal resections per year.2,6,7 However, these cutoff points
have often been imprecisely or arbitrarily defined, and there
are little data to support the use of specific volume cutoffs.
The aim of this study was to determine if an objective, ev-
idence-based threshold of operative volume associated with
improved hospital-level outcomes for esophageal resection
for cancer could be defined. Should this threshold be identi-
fied, it could potentially be considered a candidate in the cri-
teria for defining high-volume hospitals for esophageal
resection.
MATERIALS AND METHODS
Data Source
A retrospective analysis was performed using patient data collected from
the Nationwide Inpatient Sample (NIS) file between 1998 and 2003. The
NIS database comprises discharge records approximating a 20% sample
of hospital discharges in the United States and is maintained by the Agency
for Healthcare Research and Quality as part of the Healthcare Cost and Uti-
lization Project.8 It approximates 7 million patient discharge records per
year, originating from approximately 1000 different hospitals per year na-
tionwide. Data available within the NIS include patient and hospital demo-
graphics, payer information, treating and concomitant diagnoses, inpatientCardiovascular Surgery c Volume 137, Number 1 23
General Thoracic Surgery Meguid et al
G
T
SAbbreviations and Acronyms
AUC ¼ area under the curve
ICD-9 ¼ International Classification of Diseases,
Ninth Revision
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procedures, inpatient mortality, and length of stay.9 This study was ap-
proved by the Johns Hopkins Institutional Review Board, who exempted
the need for patizent consent.
Patient Population
Initial inclusion criteria for this study were patients from the NIS data-
base older than 17 years of age admitted with the diagnosis of esophageal
cancer as identified by the International Classification of Diseases, Ninth
Revision (ICD-9) diagnosis codes (150.X).10 Inclusion criteria was further
limited to patients who underwent esophageal resection as identified by
ICD-9 Clinical Modification procedure codes of 42.4 and 42.40 (esophagec-
tomy NOS), 42.41 (partial esophagectomy), 42.42 (total esophagectomy),
and 43.99 (esophagogastrectomy).2
Statistical Analysis
Multivariable analysis was performed with in-hospital death as the out-
come of record from the discharge summaries. Independent variables in-
cluded annual hospital resection volume, teaching status of the hospital
where the procedure was performed, the year the procedure was performed,
patient age, gender, race, and comorbidities as measured by the Charlson In-
dex. The NIS dataset defines teaching hospital status as hospitals that have
any American Medical Association-approved residency program, belong to
the Council of Teaching Hospitals, or have a ratio of no more than 4:1 beds
to full-time equivalent interns and residents.11
Patient comorbidities were standardized via calculation of the Deyo
modification of the Charlson Index12,13 per the methods of Romano and col-
leagues.14 A standardized calculation of patient health, the Charlson Index
is determined by weighted scoring of comorbidities, including cardiac, vas-
cular, pulmonary, neurologic, endocrine, renal, hepatic, gastrointestinal,
and immune diseases, as well as any documented history of cancer.
Individual annual hospital procedure volume was determined by calcu-
lating the number of esophageal resections performed using NIS-assigned
unique hospital identification numbers. The annual hospital mortality rate
for esophageal resections was calculated using the NIS annual hospital
resection volume for esophageal resections.
Esophageal resection volume was included as a dichotomous variable to
identify the volume cutoff that best models outcome. A series of sequential
multiple logistic regression models with a dependent variable of in-hospital
death; a set of common independent variables including patient age, gender,
race, and Charlson Index of comorbidities, procedure year, and hospital
teaching status; and a sequentially changing independent variable of dichot-
omized annual hospital resection volume were tested. This sequentially
changing variable of annual hospital resection volume was dichotomized
at 2 continuously up to 34, accounting for all of the esophageal resections
in the NIS database in the time period studied. The resection volumes within
this range are nearly continuous.
Each volume threshold dichotomizes the data and creates 2 categories for
comparison: hospitals with an annual resection volume less than that cutoff
and hospitals with an annual resection volume greater than or equal to that
cutoff. Each volume threshold is then taken forward in the multivariable
regression analysis as the independent variable.
Statistical analysis was performed using the software package STATA
10.0 (StataCorp LP, College Station, Tex). Bivariate analysis of categoric
data was performed using the chi-square test. Analysis of continuous data24 The Journal of Thoracic and Cardiovascular Surgwas performed using the Student t test. Multivariable analysis was per-
formed using linear and logistic regression models. The goodness of fit,
a measurement of the amount of variability in the data explained by the
model, was tested for each model by calculation of McFadden’s pseudo
r2 and the area under the curve (AUC). McFadden’s pseudo r2 is one such
measure of goodness of fit and has been re-scaled from 0% to 100% for
ease of interpretation and comparison. It represents the percent of variance
in a data pattern that is explained by the set of variables in a particular model.
For instance, a model explaining 7% of the variation in the data would have
a pseudo r2 of 0.07. Results are primarily reported as pseudo r2.15-17 AUC is
also reported and improves as the value approaches 1.
RESULTS
Patient Population
Analysis of the NIS dataset identified 53,168 patients with
the diagnosis of esophageal cancer, of whom 4080 (7.7%)
underwent esophageal resection, as defined by the previ-
ously listed ICD-9 Clinical Modification codes. Of these pa-
tients, 79.6% were male, and the median age was 64 years.
These esophagectomies were performed at 1506 hospitals.
The median annual hospital resection volume was 4, with
the range from 1 to 34 (interquartile range 2–9). Of the pa-
tients studied, 83.9% were white, 8.8% were black, and
the remainder were of unreported race. A total of 2883 pa-
tients (70.7%) underwent resection at teaching hospitals.
The median Charlson Comorbidity Index for the 4080 pa-
tients studied was 3, with an interquartile range of 2 to 8
and a range of 2 to 14 (of a possible range from 0 to 33). Be-
tween 444 and 552 patients underwent esophageal resection
per year. There were 387 in-hospital deaths for this patient
group, resulting in an overall in-hospital mortality rate of
9.49%. See Table 1 for demographics.
Hospital Volume–Mortality Relationship
The unadjusted annual in-hospital mortality rate was cal-
culated for each hospital. This ranged between 0% and
100%, with a median value of 0 and a mean value of
11.5% (Figure 1).
In-Hospital Mortality
A series of multiple logistic regression models were tested
with a dependent variable of in-hospital death and common
independent variables, including patient age, gender, race,
and Charlson Index of comorbidities, procedure year, and
hospital teaching status. In each model a sequentially chang-
ing variable of annual hospital resection volume threshold
was inserted, dichotomizing volume into ‘‘less than’’ versus
‘‘greater than or equal to’’ that volume threshold. The mor-
tality of patients at ‘‘high-volume’’ and ‘‘low-volume’’ hos-
pitals defined at each threshold level and the various
representations of goodness of fit (McFadden’s pseudo r2
and AUC of that particular multiple logistic regression
model) are presented in Table 2.
The values represent the average mortality rate for all hos-
pitals with esophagectomy volumes less than the volumeery c January 2009
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tals with esophagectomy volumes greater than or equal to
the volume threshold. An example of interpretation of the
values for a volume threshold of 15 would signify that hos-
pitals that perform greater than or equal to 15 resections per
year have an average postoperative mortality rate of 5.30%
compared with an average postoperative mortality rate of
10.16% at hospitals that perform less than 15 esophageal re-
sections per year (P< .001). Comparison of mortality rates
of hospitals with annual esophagectomy volumes for esoph-
ageal cancer above and below each volume threshold reveals
that they are significantly different for all volume thresholds
compared (P< .05), except when volume is greater than or
equal to 29 esophagectomies/year (P¼ .08) and greater than
or equal to 34 esophagectomies/year (P¼ .19). These results
are depicted graphically in Figure 2.
The goodness of fit of different models with different vol-
ume thresholds, as measured by McFadden’s pseudo r2,
ranged from a baseline of 3.23%, where the volume variable
is not included in the model, to 3.87%. The models with the
best fit to data were those that defined high-volume threshold
at 15 and 16, with McFadden’s pseudo r2 of 0.0387 or
3.87%. It should be noted that when the volume threshold
TABLE 1. Demographics of the study population
Characteristic n %
Esophageal cancer cases 53,168
Esophageal resections 4080 7.7%
Procedures by ICD-9-CM codes:
42.40 (esophagectomy NOS) 134 3.3%
42.41 (partial esophagectomy) 1633 40.0%
42.42 (total esophagectomy) 958 23.5%
43.99 (esophagogastrectomy) 1393 34.1%
Age median (interquartile range) 64 y 56–71 y
Male gender 3246 79.6%
Known race: 2944
White 2471 83.9%
Black 258 8.8%
Other 215 7.3%
Median Charlson Index score (interquartile
range)
3 2–8
Surgery at teaching hospital 2883 70.7%
Median annual hospital resection volume
(interquartile range)
4 2–9
Year of surgery:
1998 506 12.4%
1999 549 13.5%
2000 444 10.9%
2001 524 12.8%
2002 531 13.0%
2003 521 12.8%
2004 453 11.1%
2005 552 13.5%
In-hospital deaths 387 9.5%
ICD-9-CM, International Classification of Diseases, Ninth Revision, Clinical Modifi-
cation.The Journal of Thoracic andwas set at 13, as suggested by the Leapfrog Group, the re-
sulting model had a McFadden’s pseudo r2 of 3.80%. A
graphic depiction of the changes in goodness of fit as defined
by McFadden’s pseudo r2 of different volume thresholds is
shown in Figure 3. The goodness of fit for the dichotomous
model improved as the volume threshold was increased from
1 to 15, peaking at a threshold of 15 resections per year. Sub-
sequently, the goodness of fit of the model deteriorated as
the volume threshold was further increased.
The results from calculation of the AUC as a measure of
goodness of fit are reported in Table 2. The range in the cal-
culated values of AUC is similar to that of the McFadden’s
pseudo r2; therefore, our discussion focuses on the results of
the McFadden’s pseudo r2.
CONCLUSIONS
Much attention has been focused on defining centers of
excellence. To date, the role of hospital volume has been
emphasized. By using the NIS dataset, we examined the re-
lationship between surgical volume and mortality. We found
this well-established inverse relationship persists in the NIS
dataset. This is demonstrated in Figure 1, where a clear trend
toward diminishing unadjusted annual in-hospital mortality
is present.
Given the well-established inverse relationship between
esophageal resection volume and in-hospital mortality, we
sought to use statistical modeling to define a single value
cutoff at which there is significantly reduced mortality.
This would allow us to better determine hospital operative
volumes required for improved outcomes for esophageal re-
section for cancer.
On analysis of dichotomous volume cutoff modeling, we
found a statistically significant difference between mortal-
ity rates at hospitals with esophagectomy volumes above
FIGURE 1. Graph of in-hospital mortality rates for individual hospitals by
annual hospital esophageal resection volume. These data represent the an-
nual hospital mortality rates of in-hospital death at 1506 different hospitals.
The data points have been staggered to illustrate the trend because of the
high frequency of overlapping values.Cardiovascular Surgery c Volume 137, Number 1 25
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hospitals with esophagectomy volumes below the volume
threshold, irrespective of annual hospital resection volume
cutoff (Figure 2). For example, defining high volume at
13 or more, as suggested by the Leapfrog Group,5 the
resulting high-volume hospitals have a mortality rate of
5.39% in comparison with 10.26% at low-volume hospi-
tals (P< .001). However, even defining the high-volume
threshold at a volume of 2 resections per year produces sig-
nificant differences in mortality rates between hospitals
with esophagectomy volumes above and below that thresh-
old. Our study confirms previous findings by Christian and
colleagues,18 who also showed that the Leapfrog standards
may not have been optimal for other surgical procedures;
for example, they empirically found different thresholds
for coronary artery bypass graft, abdominal aortic aneu-
rysm, and esophagectomies compared with the Leapfrog
standards; moreover, in contrast with Leapfrog, they found
no good empiric threshold for carotid endarterectomies.
This finding reveals the true conundrum of volume mod-
eling: No matter what the volume cutoff is set at, the mortal-
ity rates above and below it are almost always significantly
different. Therefore, to determine the best model for high-
volume centers, we examined goodness of fit of the model
to the data instead of differences in mortality.
When multiple logistic regression of in-hospital death
after esophageal resection includes the variables of patient
age, gender, race, and Charlson Index of comorbidities
and calendar year, but not resection volume, the resulting
model explains 3.23% of the variance in the data. Adding
hospital volume as a dichotomous variable, ranging from 2
to 34 resections per year, improves the explanatory power
TABLE 2. Mortality rates and goodness of fit to data of multiple high-volume threshold modelsy
Volume
threshold
Mortality rate at centers
with volume less than volume
threshold (%)
Mortality rate at centers with
volume equal to or greater than
volume threshold (%) P value
McFadden’s
pseudo r2 (shown as%) AUC
Baseline - - - 3.23 0.6354
1 - 9.94% - 3.31 0.6364
2 13.31% 8.63% <.001 3.43 0.6431
3 12.38% 8.03% <.001 3.46 0.6430
4 11.54% 7.71% <.001 3.35 0.6392
5 11.31% 7.36% <.001 3.44 0.6414
6 11.04% 7.09% <.001 3.43 0.6412
7 10.96% 6.54% <.001 3.52 0.6425
8 10.86% 6.35% <.001 3.56 0.6418
9 10.68% 5.98% <.001 3.57 0.6435
10 10.58% 5.37% <.001 3.73 0.6440
11 10.50% 5.22% <.001 3.73 0.6440
12 10.35% 5.31% <.001 3.79 0.6449
13* 10.26% 5.39% <.001 3.80 0.6450
14 10.22% 5.50% <.001 3.76 0.6444
15 10.16% 5.30% <.001 3.87 0.6465
16 10.14% 5.26% <.001 3.87 0.6461
17 10.08% 5.39% .001 3.76 0.6441
18 10.01% 5.57% .002 3.67 0.6425
19 9.97% 5.57% .003 3.69 0.6428
20 9.95% 5.10% .002 3.64 0.6417
21 9.92% 5.14% .003 3.64 0.6417
23 9.92% 4.87% .002 3.69 0.6427
24 9.91% 4.60% .002 3.71 0.6437
25 9.83% 4.33% .004 3.70 0.6449
26 9.75% 4.43% .012 3.60 0.6430
27 9.71% 4.52% .021 3.50 0.6408
28 9.67% 4.67% .040 3.50 0.6408
29 9.63% 4.92% .080 3.40 0.6387
30 9.61% 1.56% .029 3.51 0.6390
34 9.54% 2.94% .191 3.31 0.6359
AUC, Area under the curve. The relationship of different high-volume thresholds to mortality rates and the goodness of fit (McFadden’s pseudo r2 and the AUC) of each model. An
example of interpretation of the values for a volume threshold of 15 would signify that, on average, hospitals that perform 15 esophageal resections per year have a mortality rate
of 5.30%, compared with 10.16% at hospitals that perform<15 resections per year. The P value for the chi-square statistic of these mortality rates is< .001, and this model has
a pseudo r2 of 3.87% and an AUC of 0.6465. *The definition of ‘‘high volume’’ as suggested by the Leapfrog Group.5 yMultivariable logistic regression model adjusted for patient
age, gender, race, and Charlson Index of comorbidities, procedure year and hospital teaching status, and a sequentially changing independent variable of dichotomized annual
hospital resection volume.26 The Journal of Thoracic and Cardiovascular Surgery c January 2009
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3.87%. By using these criteria, the best model is one that
defines a ‘‘high-volume’’ cutoff as 15 or more esophageal
resections per hospital per year, because this has the highest
McFadden’s pseudo r2 value and accounts for the most
variability in the data. It is interesting to note that the inclu-
sion of volume into the multivariable model only accounts
for a maximum of 0.64% of the variability in the data.
Therefore, varying the volume threshold did not substan-
tially change the explanatory power of the different
dichotomous volume models for defining high-volume
centers for esophageal resection. This is noteworthy given
the attention that resection volume for esophageal surgery,
among other procedures, has been afforded in the literature.
Although there is an overall trend of increased operative
volume associated with decreased postoperative mortality,
a curious finding is present in Table 2: The mortality rate
at centers with annual resection volumes equal to or greater
than the volume threshold tested do not necessarily have
continuously diminishing values. The mortality rates given
in Table 2 are calculated by averaging the mortality rates
of every hospital that performs esophagectomies above or
below the volume threshold. As can be seen, increased vol-
ume does not strictly correlate with decreased postoperative,
in-hospital mortality. Therefore, factors other than annual
hospital volume must certainly contribute to mortality rate.
The NIS database was chosen over other available data-
bases because of the extensive nature of its records and the
ability to provide a large sample size with which to compare
outcomes across the United States. As in analyses of all ad-
ministrative databases, the current analysis has several lim-
itations. They include the retrospective database design
FIGURE 2. Graph showing the different mortality rates above and below
each volume threshold. Squares indicate the mortality rates of hospitals with
annual esophagectomy volumes for esophageal cancer less than the volume
threshold. Triangles indicate the mortality rates of hospitals with annual
esophagectomy volumes for esophageal cancer greater or equal to the vol-
ume threshold. The difference between each pair of mortality rates at a given
annual hospital volume is statistically significant for all volume thresholds
except more than 29 and 34. Associated data are listed in Table 2.The Journal of Thoracic andand the associated constraints at the level of the data used
for analysis, the inability to account for surgeon experience,
the difficulty in examining other postoperative outcomes
such as cause of death, and the inability to measure 30-day
mortality, as opposed to in-hospital death. In examining
the NIS database, we are unable to check the accuracy of
the diagnostic and procedure coding. Although the validity
of the coding may be verified, the appropriateness of the
coding used for diagnosis and procedures may not. How-
ever, we assume that this type of error would be equally dis-
tributed across all groups of interest. The overall in-hospital
mortality rate of 9.49% is consistent with reported mortality
rates of other large series using 30-day mortality,19 adding
validity to the data reported in the NIS database, and our
use of in-hospital mortality as an outcome. In addition, it
has been argued that for complex operations, in-hospital
mortality may be a better measure of postoperative mortality
than 30-day mortality because of improved capabilities of
intensive care management to rescue critically ill patients.11
Other outcomes, such as complications associated with
surgery or perioperative care and postdischarge outcomes,
including deaths occurring outside of the surgical hospitali-
zation, are not ascertainable from this database. Complica-
tions occurring after surgery cannot be differentiated from
comorbidities existing preoperatively. This prevents us
from examining and comparing postoperative complica-
tions. In addition, because these patients have undergone
esophagectomy for cancer, it would be meaningful to mea-
sure disease-free and overall survival. When calculating
the Charlson Index we assume that preexisting conditions
and those same conditions arising after surgery have the
same impact on patient outcomes. Proxies of non-death hos-
pital outcome, including the need for postoperative proce-
dural intervention and length of hospital stay, have been
used by others studying different databases.20,21
FIGURE 3. Graph of goodness of fit versus annual hospital resection vol-
ume. Each point represents one resection volume. McFadden’s pseudo r2 is
shown as percent. Dashed line represents ‘‘baseline’’ McFadden’s pseudo r2
from the model without resection volume (3.23%).Cardiovascular Surgery c Volume 137, Number 1 27
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influence postoperative outcomes at the hospital level. These
focus on processes of care, which may be associated with im-
proved outcome after surgery. Billingsley and colleagues21
have correlated improved outcomes after surgery for colon
cancer with the presence of solid organ transplantation teams,
as a proxy for patient care indices associated with improved
postoperative outcomes. Other processes of care studied and
correlated to improved outcomes include dedicated surgical
intensive care units managed by dedicated intensive care spe-
cialists,3,22 patient safety initiatives,23 and the use of multi-
disciplinary teams and standardized clinical care pathways
at high-volume centers, for example.24 We believe it is likely
that these hospital-level processes of care are more readily
available at high-volume centers, and as such, high-volume
status may serve as a proxy for them in large administrative
databases such as the NIS.
We show that, although there is a trend toward an inverse
relationship between volume and mortality, volume is not
sufficient for defining centers of excellence. Volume seems
to function as an imperfect surrogate for other variables,
which may better define centers of excellence, such as quality
of dedicated intensive care, postoperative monitoring, clini-
cal care pathways, and other processes of care.20,21,25,26 Ad-
ditional work is needed to identify those variables associated
with improved outcome after esophageal resection.
In addition, using a comparison of mortality rates and
goodness of fit of different volume thresholds, we were
unable to identify a clear, optimal volume threshold for
improved outcomes after esophagectomy for esophageal
cancer. We conclude that the use of volume thresholds alone
for determining centers of excellence does not appropriately
represent the variance in the data or necessarily guide appro-
priate decision making and should be avoided.
The authors thank Nita Ahuja, MD, for critical review of the
methods used in this study.
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Discussion
Dr A. Pennathur (Pittsburgh, Penn). Dr Meguid, that was an
excellent presentation and I congratulate you on your efforts to de-
fine a cutoff volume. Dr Meguid and colleagues from the Johns
Hopkins Hospital have analyzed the outcomes of more than 3000
patients from more than 1000 hospitals derived from the NIS.
They analyzed the variable of esophagectomy volume with the pri-
mary outcome being in-hospital mortality. Their main objective
was to evaluate how valid hospital volume cutoffs are for defining
centers of excellence. The number of esophagectomies performed
in these hospitals ranged from a minimum of 1 to a maximum of
29. The median was somewhat lower, just 4 esophagectomies per
year. The overall mortality rate was 9.9%. After using esophagec-
tomy volume as a dichotomous variable initially, they went on to
perform a goodness-of-fit model, concluding that they were unable
to establish a cutoff value. They then concluded that volume cutoffs
cannot be used to determine centers of excellence and further work
is needed to investigate this.
Several large single-institution series have been published with
remarkably low mortality rates, including your institution; ours,ery c January 2009
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Swhere in a series of 222 consecutive esophagectomies had a mortal-
ity rate of 1.4%; and excellent results from other larger series, such
as those from Drs Orringer, Altorki, and Swanson, to name a few.
However, this relationship between esophagectomy volume and
outcome is complex, with several factors playing a role. These fac-
tors include the surgeon volume, specialty training of the surgeon,
comorbidities in the patient, and provision for critical care services.
Adding to these factors is the case mix seen at a particular hospital,
which may contribute. For example, the referral pattern of a private
hospital may be much different than that of an inner-city hospital.
So my first question is, given the complexities of the volume–
outcome relationship, do you think it is possible that you can reduce
this to a single number across all hospitals in the United States with-
out taking into consideration other important factors, such as sur-
geon volume, expertise, and patient population?
Dr Meguid. The impetus for our study was the curiosity to see
how the seemingly arbitrary cutoff of 13 fared against other volume
cutoffs. We expected to see a dramatic difference in mortality rates,
for instance, but were, quite frankly, shocked by the apparent lack
of the difference between choosing 13 and any other volume cutoff.
As you point out, the relationship between individual and hospi-
tal operative volume and the processes of care and outcome is very
complex. Unfortunately, it’s difficult to study the effect of different
processes of care because of lack of information available in these
multi-institutional databases. Using a patient-focused database,
such as the Society of Thoracic Surgeons’ database, would be ideal;
however, at the present time data are lacking for such analysis, and
unfortunately, use of all of our own single-institution databases
lends to bias.
Dr Pennathur. The second question is, did you first conduct an
analysis of all the data in this particular cohort of patients to estab-
lish a functional relationship between mortality and volume in this
cohort before dichotomizing these patients?
Dr Meguid. Yes, sir. Before dichotomizing the data at the differ-
ent cutoff points, we did examine the unadjusted relationship between
volume and in-hospital death and found this to be an inversely linear
relationship. When we adjusted for age, patient gender, patient race,
and patient comorbidities, we also saw that that persisted.
Dr Pennathur. The next thing is, using mortality as an outcome
variable, how do you do a risk-adjusted mortality rate? For example,
from your article, when the volume was greater than 10, the mortal-
ity rate was 5.3%. However, when the volume was greater than or
equal to 29, the mortality was actually higher; it was 8.6%. Is this
because sicker patients are going to high-volume hospitals? Perhaps
a more useful reporting might be a risk-adjusted mortality rate.
Dr Meguid. Yes, I fully agree with you. In dichotomizing a con-
tinuous variable, one is combining all of the values below and
above that cutoff into 2 values. As a result, the lowest mortality
rate was observed at a volume cutoff of 10, but when the volume
cutoff was raised, a lower mortality rate was not observed. Again,
that’s one of the prime complications of using a dichotomous
model for continuous variables.
Dr Pennathur. Along the same lines, are you going to attempt to
take other variables into consideration, such as nutritional status of
patients, which has been shown to be important; socioeconomic
status; specialty training of the surgeon, which has been show to
be important; and elective versus emergent procedures, all of which
are going to have an impact on mortality?The Journal of Thoracic andDr Meguid. Yes, I fully agree with you regarding the impor-
tance of these factors. Unfortunately, because of the administrative
nature of the NIS database, one is unable to account for many ger-
mane factors, such as cancer staging, preoperative nutritional sta-
tus, and neoadjuvant or postoperative chemo- and radiotherapy.
One can control for gender, some patient demographics, which
aren’t necessarily specific to operative mortality, the Charlson
Comorbidity Index, and some hospital demographics. This is,
again, a big limitation with these administrative datasets.
Dr M. Jaklitsch (Boston, Massachusetts). I’m just deeply con-
cerned that your highest output hospital was 29 cases per year, and
we all know of excellent academic centers of excellence that do
more than 29 per year. So either they are not in the database, the
most sterling outcomes are not in this database, or they are in this
database but with incomplete data. I don’t know how you can
draw conclusions from this if either 1 of those 2 cases is true.
Dr Meguid. Dr Jaklitsch, that’s an excellent point. In fact, when
we looked at a similar example using pancreatic resections, we found
a similarly small range, and that motivated us at Johns Hopkins to look
into why we don’t find institutions with 100 resections per year.
Subsequently, in this nationally representative sample, we find that
a lot of the hospitals are lower-volume hospitals and we don’t see
a lot of the larger academic centers included every year in this
database. So that is, again, a limitation specific to the NIS database.
Dr Jaklitsch. Can I ask, how many cases a year do you do at
Hopkins?
Dr Meguid. I’m not sure, I believe it’s in the 50s. Dr Yang?
Dr Yang. It’s about 75.
Dr Jaklitsch. So Hopkins’ data, for instance, is not in this?
Dr Meguid. It’s not in the NIS, no, sir.
Dr T. Grodzki (Szczecin, Poland). Did you make a differentiation
between hospital volume and surgeon volume? Because it’s not the
same. And did you analyze the mortality reasons? Were they due
to technical failure or the imperfections in postoperative care?
Dr Meguid. Those are very good points. We chose to use hos-
pital volume, although we could have examined physician volume.
We chose to use hospital volume because that is what has been used
in other models, including the Leapfrog Group, and we wanted to
analyze these cutoffs in particular. Unfortunately, we can’t tease
out what postoperative complications occur in these patients be-
cause of the limitations of this dataset.
Dr D. Wood (Seattle, Wash). I have the same concern that Dr
Jaklitsch expressed, but also a concern about how you have repre-
sented the conclusion. It would seem that volume is an important
surrogate for mortality outcomes, yet you have found that there is
not a good cutoff for volume. That does not mean that volume
isn’t important, which it sounds like in the conclusion. Rather, vol-
ume is very important; we just cannot create a cutoff to define an
‘‘adequate’’ volume. So I think that it is very important to refine
the message, because policymakers, like Leapfrog, need a clear
message that volume is important in terms of quality of outcomes,
unless you think that this research disputes that premise.
Dr Meguid. Dr Wood, you have made an excellent point. I don’t
want to misrepresent our findings. Our findings are that a specific
cutoff is an inappropriate way to determine centers of excellence.
However, in this example, increased volume is correlated with
decreased complications and mortality, and that should not be
overlooked.Cardiovascular Surgery c Volume 137, Number 1 29
